The 'rejuvenation' business is growing in the US through the infusion of someone else's blood - ForumDaily
The article has been automatically translated into English by Google Translate from Russian and has not been edited.
Переклад цього матеріалу українською мовою з російської було автоматично здійснено сервісом Google Translate, без подальшого редагування тексту.
Bu məqalə Google Translate servisi vasitəsi ilə avtomatik olaraq rus dilindən azərbaycan dilinə tərcümə olunmuşdur. Bundan sonra mətn redaktə edilməmişdir.

In the USA, the business of 'rejuvenation' through the infusion of someone else's blood is growing

The last few years in the United States is gaining popularity an unusual way to combat aging: through the transfusion of blood from young donors. Even startups have appeared, ready to perform this procedure for 8 thousand dollars. Their employees promise the effect of "rejuvenation", if you regularly pour in someone else's blood. This interested in including businessmen from Silicon Valley, who are engaged in "biohacking."

Фото: Depositphotos

At the same time, scientists consider the procedure unproven and even dangerous, and the authors of the “rejuvenation” technique are scammers. In February, 2019 of the United States joined the FDA for the fight against young blood transfusions, which warned potential patients of the wasting of thousands of dollars, writes TJ.

"Vampire" startup

Discussing other people's blood transfusions for "rejuvenation" started from a California startup Ambrosia. This is a medical project that created 34-year-old Dr. Jesse Karmazin. He graduated from Stanford Medical School, but does not have a license to practice medicine. In 2017, Karmazin founded a company that soon became known as “vampire”.

We are talking about the infusion of plasma to people - the liquid part of human blood, from which substances necessary for vital activity are transferred to other tissues. Interest in the procedure appeared after a study at Harvard: scientists poured the blood plasma of young mice to old mice and concluded that those with improved memory and ability to perform tasks.

Ambrosia decided to do the same with people.

“It's like a reboot,” - described effect transfusion Karmazin. According to him, the aging process after the procedure seems to be reversed.

Over the course of several years, Ambrosia specialists provided transfusions to 150 patients aged 35 to 92 years. The age of blood donors ranged from 16 to 25 years. The startup sold a liter of young plasma for 8 thousand dollars, and two liters for 12 thousand dollars. The company opened several branches in different cities of the United States and announced the launch of its first clinic.

One of Ambrosia's investors is billionaire Peter Thiel. Earlier media wrotethat, even before investing in a startup, he spent 40 thousands of dollars per quarter on blood plasma infusions from 18-year donors. Til claimed he was not an Ambrosia customer. According to rumors, transfusions were practiced by other people from Silicon Valley who were interested in "biohacking."

Other startups like Alkahest study the procedure in order to find an effective cure for Alzheimer's disease. But Ambrosia has more practical goals: to give a person the opportunity to “look younger”.

“This procedure will not help you lose 50 years, but you will feel an improvement. Plasma increases protein levels, bringing them closer to the same level as donors. The organs return to their youthful state,” said Jesse Karmazin, head of Ambrosia.

With this he refuses to answer the question whether he underwent the “rejuvenation” procedure.

Fears of scientists

The head of Ambrosia calls plasma infusion to people "the standard procedure" - and in general he is right. The procedure is approved by the Food and Drug Administration (FDA), but is not used as an “anti-aging therapy,” but mainly for severe burns and impaired blood clotting.

If at first the scientific community and the media were suspicious of the Californian company, then recently they have openly opposed the “rejuvenation” method. The main argument is that there is still no weighty evidence that regular infusion of blood plasma somehow helps the human body.

Scientists have conducted several studies on this topic, but their results have not yet been made public. The Ambrosia team also made its own tests, infusing blood to the subjects. However, they still paid for the procedure, although usually patients in the United States undergo experimental tests for free. Also, the placebo was not used in the study: “It is not fair to transfer it to someone who paid 8 thousands of dollars.”

Uproxxx Edition suspected Karmazina and his team in fraud, comparing a startup with the organization of the "worst music festival in history" Fyre. And Popular Science journalist Nicole Wetsman directly wrote: “Please do not spend 8 thousand dollars on the infusion of young blood. There are many ways to spend better money. ”

The arguments of the media repeat the statements of scientists: without evidence of the benefits of blood injection, the work of such startups seems to be “pumping out” money from customers who dream of getting younger.

Professors of the University of California Irina and Michael Conboy, who studied the benefit of plasma transfusions in mice, also spoke out against the procedure. They remindedthat there is a risk of rejection of donor cells, and the procedure will ultimately do more harm than good. To them joined New York University Professor Mark Siegel.

“There are still risks of complications. If you're in an accident and risk dying without a blood transfusion, it's worth it. But you shouldn’t give a transfusion unless absolutely necessary,” said Michael Conboy, Professor at the University of California.

Critics First Victory

February FDA 19 head Scott Gottlieb officially She urged Americans do not transfuse young blood to fight aging. He expressed concern about the “growing number of such clinics” and the high price of the service, but did not mention Ambrosia directly. According to him, the companies that promise youth with the help of blood are “unscrupulous actors” who simply rob patients.

“There is no evidence of benefit from plasma infusions from young donors. There are also risks associated with transfusions. The procedure should not be considered safe or effective. We caution customers against undergoing the procedure,” the FDA said in a statement.

Karmazin did not comment on the statement of the American regulator. But a few hours after the warning, all the information about the service and studies disappeared from the Ambrosia website. At this point a disclaimer appeared: "In accordance with the FDA statement from February 19 of 2019, we stop treating patients." Whether the startup will resume work is still unknown.

Read also on ForumDaily:

When is old age and what is it: attitude to age in Russia, the USA and the world

Awesome feat: American saved 2687 lives

Silicon Valley start-ups against death are gaining popularity

7 Cosmetic Injection Myths

In the U.S. Startup donation
Subscribe to ForumDaily on Google News

Do you want more important and interesting news about life in the USA and immigration to America? — support us donate! Also subscribe to our page Facebook. Select the “Priority in display” option and read us first. Also, don't forget to subscribe to our РєР ° РЅР ° Р »РІ Telegram  and Instagram- there is a lot of interesting things there. And join thousands of readers ForumDaily New York — there you will find a lot of interesting and positive information about life in the metropolis. 



 
1068 requests in 1,075 seconds.